Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-Term Survival after Kidney Transplantation.

The New England journal of medicine·2022

Same author

Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients.

International journal of dermatology·2022

Same author

Acute Myeloid Leukemia Presenting Less Than 3 Weeks After Living Donor Kidney Transplant: A Case Report.

Transplantation proceedings·2021

Same author

Evaluation of a multimodal analgesic regimen on outcomes following laparoscopic living donor nephrectomy.

Clinical transplantation·2021

Same author

Evaluation of cytomegalovirus prophylaxis in low and intermediate risk kidney transplant recipients receiving lymphocyte-depleting induction.

Transplant infectious disease : an official journal of the Transplantation Society·2021

Same author

COVID-19 in Solid Organ Transplant Recipients: Observations From Connecticut.

Transplantation·2020

Search research articles

Related Experiment Video

Updated: May 23, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Recurrent hepatitis C after liver transplantation.

Patricia Sheiner¹, Caroline Rochon

¹Hartford Hospital, Hartford, CT, USA. psheiner@harthosp.org

The Mount Sinai Journal of Medicine, New York

|April 14, 2012

Summary

Hepatitis C virus (HCV) recurrence after liver transplant is common, often progressing to cirrhosis. Risk factors like donor age and high viral load impact severity, while current treatments show limited success.

Area of Science:

Hepatology
Transplantation Immunology
Virology

Background:

Hepatitis C virus (HCV) infection is the primary reason for liver transplantation in the US.
While HCV recurrence post-transplant is universal, its progression and severity vary among patients.
A significant percentage (10-20%) of patients develop cirrhosis within five years post-transplant.

Purpose of the Study:

To review the natural history of recurrent hepatitis C virus infection after liver transplantation.
To identify risk factors associated with severe post-transplant hepatitis C.
To evaluate the efficacy and limitations of current and emerging treatments for recurrent HCV.

Main Methods:

Review of existing literature on post-liver transplant hepatitis C.

More Related Videos

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 23, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Analysis of identified risk factors for disease progression.

Assessment of treatment outcomes for antiviral therapies in the post-transplant setting.

Main Results:

Recurrent HCV infection typically progresses rapidly, with 10-20% developing cirrhosis within 5 years.
Risk factors for severe recurrence include donor age, female sex, rejection treatment, preservation injury, and high pre/early post-transplant viral load.
Interferon and ribavirin yield limited sustained virologic response (8-30%) with significant side effects.

Conclusions:

Hepatitis C virus recurrence post-liver transplant necessitates careful monitoring due to rapid progression and potential for cirrhosis.
Identifying and mitigating risk factors is crucial for improving outcomes.
Current antiviral treatments offer suboptimal efficacy, highlighting the need for novel therapeutic strategies, including protease inhibitors currently in clinical trials.